For Industry

 

 

We recognise the importance of working with manufacturers and developers to identify and prioritise emerging and new health technologies and welcome the opportunity to discuss development pipelines with commercial developers.


If you wish to send us information about any development you think we should investigate please complete the relevant information pro-forma or email us at nihrhsric@contacts.bham.ac.uk. We undertake to respect any confidential or commercially sensitive information you provide.


Pharmaceutical industry


UK PharmaScan is a secure horizon scanning database populated by manufacturers with information on new medicines in development from up to three years before their launch in the UK or start of phase III clinical development, whichever is the earlier. UK PharmaScan is designed to reduce duplication of information provided to UK horizon scanning organisations and to support better NHS planning for the introduction of new medicines to patients. The HSRIC is a member of the UK PharmaScan Oversight & Governance Committee and the User Group. We encourage pharmaceutical companies to register for UK PharmaScan and input information on relevant products.


Medical devices and diagnostic industry

Do you want to inform the NHS & other key decision-makers your technology is coming to the UK soon?


One of the key roles of the NIHR Horizon Scanning Research and Intelligence Centre (HSRIC) is to produce ‘alerts’ that give a brief overview of innovative medtech (medical devices, diagnostic tests, imaging techniques or procedures) around or up to two years before becoming commercially available in the UK. They provide valuable early intelligence for key policy and decision makers in the NHS and the NIHR research community, and healthcare organisations including commissioners, hospital and community providers, health professionals and procurement staff, as well as patients.

email: nihrhsric@contacts.bham.ac.uk  


Do you want to link in to the UK’s innovation network?


The Knowledge Transfer Network (KTN) is the UK’s innovation network. It brings together business, the science base and funders to develop new products, processes and services. It helps business to grow the economy and improve people’s lives by capturing maximum value from innovative ideas, scientific research and creativity. Established by Innovate UK to build better links between science, creativity and business, the Knowledge Transfer Network has specialist teams covering all significant sectors of the economy.

email: enquiries@ktn-uk.org


Do you want to link in to the NIHR infrastructure?


The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. The NIHR has transformed research in the NHS and its people, programmes, centres of excellence and systems represent the most integrated health research system in the world. The NIHR Office for Clinical Research Infrastructure (NOCRI) helps potential research partners, including the life sciences industry and charities work with the NIHR's expert and extensive research infrastructure. NOCRI is a unique resource for the global life sciences industry - improving the quality, efficiency and success of translational research.

email: nocri@nihr.ac.uk


Do you want to know more about innovation activity at NHS England?


NHS England (NHSE) oversees the budget, planning, delivery and day-to-day operation of the NHS in England. You can find out more about their innovation activity at www.england.nhs.uk/ourwork/innovation/. NHS England has an innovation web portal called Innovation Exchange for anyone to share their ideas and meet other people with interest and expertise in similar fields. Innovation Exchange is the central point for anyone interested in innovation in healthcare in the NHS.

email: england.innovation@nhs.net


Do you have an innovative medical technology with potential value for the UK’s NHS?

The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. Their guidance takes several forms, including medical technologies and diagnostics guidance that helps to ensure that the NHS is able to adopt clinically and cost effective technologies rapidly and consistently. Also their interventional procedures guidance recommends whether new or novel procedures being used for the first time in the NHS are effective and safe enough for use. NICE welcomes routine engagement with companies, in confidence and without obligation, to understand more about their products and to advise on their suitability for evaluation.

email: medtech@nice.org.uk